title: Portal inflow and pressure changes in right liver living donor liver transplantation including the middle hepatic vein.
abstract: The middle hepatic vein may be included in right liver living donor liver transplantation (LDLT) to optimize hepatic venous outflow. We studied the graft's ability to relieve portal hypertension and accommodate portal hyperperfusion with portal manometry and ultrasonic flowmetry. Surgical outcomes with respect to portal hemodynamometry were also investigated. The ages of the recipients and donors for 46 consecutive LDLT procedures were 50 (range, 16-66 years) and 31 years (range, 18-54 years), respectively. The graft to standard liver volume ratio was 47.4% (range, 32.4%-69.0%). The hospital mortality rate was 4.4% as 2 recipients died from a subarachnoid hemorrhage and sepsis. The portal pressure dropped by 8 mm Hg (range, -7 to 19 mm Hg) from 23 (range, 8-37 mm Hg) to 14 mm Hg (range, 10-26 mm Hg) after graft implantation. The portal inflow positively correlated with the portal pressure before native liver hepatectomy (R(2) = 0.305, P = 0.001) and not with the graft size. The portal inflow increased from 81 mL/minute/100 g (range, 35-210 mL/minute/100 g) before donor right hepatectomy to 318 mL/minute/100 g (range, 102-754 mL/minute/100 g) after graft implantation. The graft portal inflow had a positive linear correlation with the recipient portal pressure before native liver total hepatectomy (R(2) = 0.261, P = 0.001) but not after graft implantation, and it had a negative correlation with the graft to standard liver volume ratio (R(2) = 0.247, P = 0.001). Only 1 of the graft biopsies showed moderate sinusoidal congestion. Twelve recipients had Clavien grade 2+ complications that were not related to the portal inflow and pressure or graft size. Right liver LDLT including the middle hepatic vein effectively lowered the recipient portal pressure by allowing unimpeded venous outflow.
authors.affiliation: Department of Surgery, University of Hong Kong, Queen Mary Hospital, Hong Kong, China.
authors.forename: See Ching
authors.initials: SC
authors.lastname: Chan
authors.forename: Chung Mau
authors.initials: CM
authors.lastname: Lo
authors.forename: Kelvin K C
authors.initials: KK
authors.lastname: Ng
authors.forename: Irene O L
authors.initials: IO
authors.lastname: Ng
authors.forename: Boon Hun
authors.initials: BH
authors.lastname: Yong
authors.forename: Sheung Tat
authors.initials: ST
authors.lastname: Fan
mesh_terms: D000293:Adolescent; D000328:Adult; D001706:Biopsy; D001783:Blood Flow Velocity; D005260:Female; D006498:Hepatectomy; D006503:Hepatic Veins / Q000503:physiopathology / Q000601:surgery*; D006723:Hong Kong; D017052:Hospital Mortality; D006801:Humans; D006975:Hypertension, Portal / Q000401:mortality / Q000503:physiopathology / Q000601:surgery*; D016014:Linear Models; D016031:Liver Transplantation / Q000009:adverse effects / Q000401:mortality; D019520:Living Donors; D008297:Male; D008365:Manometry; D008875:Middle Aged; D017082:Portal Pressure; D011169:Portal Vein / Q000503:physiopathology / Q000601:surgery*; D011446:Prospective Studies; D012039:Regional Blood Flow; D012212:Rheology; D013997:Time Factors; D016896:Treatment Outcome; D055815:Young Adult